AGT and hypertensive disorder: Furthermore, Park et al. [32] observed the ability of rosuvastatin to protect against angiotensin II-induced inflammatory and profibrotic activation and renal injury in a transgenic model of angiotensin II-induced hypertension and target-organ damage.